SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences informs about board meeting

05 Aug 2024 Evaluate

Eiko Lifesciences has informed that as required under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, 13th August, 2024 to consider and approve the following: The Unaudited Financial Results (Standalone & Consolidation basis) of the Company for the quarter ending on 30th June, 2024 in accordance with Regulation 33 of the SEBI Listing Regulation; Any other matter with the permission of the chair. Further, pursuant to the Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters, Designated Employees and Connected Persons of the Company and pursuant to SEBI (Prohibition of insider Trading) Regulations 2015, the Trading Window for dealing in securities of the Company for all the Designated Persons is already closed with effect from 01st July, 2024, which shall continue to remain closed for all the Designated Persons and their Immediate Relatives till 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ending on 30th June, 2024.

The above information is a part of company’s filings submitted to BSE.

Eiko Lifesciences Share Price

51.51 -1.59 (-2.99%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2732.95
BASF India 3291.00
Tata Chemicals 719.95
Pidilite Inds. 1503.95
Deepak Nitrite 1666.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×